[{"from": "human", "value": "Create a molecule with the structure as the one described. The molecule are benzoxazole derivatives developed by FoldRX. Tafamidis is structurally similar to diflusinal.  Tafamidis was granted an EMA market authorisation on 16 November 2011 and FDA approval on 3 May 2019."}, {"from": "gpt", "value": "[C][=C][C][=C][Branch1][#Branch2][C][=C][Ring1][=Branch1][C][=Branch1][C][=O][O][O][C][=Branch1][Ring2][=N][Ring1][#Branch2][C][=C][C][=Branch1][=Branch2][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][Cl][Cl]"}]